Marketing SARS-CoV-2 Vaccines: an Opportunity to Test a Nobel Prize-Winning Theory
J Gen Intern Med
.
2021 Nov;36(11):3565-3567.
doi: 10.1007/s11606-021-06927-x.
Epub 2021 May 26.
Authors
Amol A Verma
1
2
,
Kieran L Quinn
2
3
,
Allan S Detsky
4
5
Affiliations
1
Division of General Internal Medicine and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
2
Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
3
Department of Medicine, Sinai Health System and University Health Network, Toronto, ON, Canada.
4
Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
[email protected]
.
5
Department of Medicine, Sinai Health System and University Health Network, Toronto, ON, Canada.
[email protected]
.
PMID:
34037921
PMCID:
PMC8152193
DOI:
10.1007/s11606-021-06927-x
No abstract available
Publication types
Editorial
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Marketing
Nobel Prize*
SARS-CoV-2
Substances
COVID-19 Vaccines